Trials of locoregional therapies inspired by SABR-COMET
Authors:
- 1 October 2020
- journal article
- letter
- Published by Elsevier in The Lancet
- Vol. 396 (10256) , 956-957
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- NRG Oncology/RTOG 0438: A Phase 1 Trial of Highly Conformal Radiation Therapy for Liver MetastasesPractical Radiation Oncology, 2019
- Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trialThe Lancet, 2019
- Radiofrequency and Microwave Ablation Compared to Systemic Chemotherapy and to Partial Hepatectomy in the Treatment of Colorectal Liver Metastases: A Systematic Review and Meta-AnalysisCardioVascular and Interventional Radiology, 2018
- Dosimetric analysis of liver toxicity after liver metastasis stereotactic body radiation therapyPractical Radiation Oncology, 2017
- Radiofrequency ablation is a valid treatment option for lung metastases: experience in 566 patients with 1037 metastasesAnnals of Oncology, 2015